why choose us

First received: June 26, 2023

Clinical Trial: Oregon PrEP at Home Study

Study Status: Completed

Recruit Status: RECRUITING

Condition: HIV/AIDS

Study Type: OBSERVATIONAL


Official Title: Oregon PrEP at Home Study: Real-world Delivery of Long-acting Cabotegravir (CAB-LA) for HIV Pre-exposure Prophylaxis (PrEP) Through a Tele-PrEP Program and a Home Infusion Program Partnership to Addre

Brief Summary: This demonstration study will evaluate the real-world implementation of long-acting cabotegravir (CAB-LA) for HIV pre-exposure prevention (PrEP) through a partnership between the OHSU Tele-PrEP Program (TPP) and the OHSU Home Infusion Pharmacy (HIP).The study will perform a formative evaluation of the TPP/HIP partnership to determine its merit and worth, with revisions made as needed to improve the program, which is reflective of a real-world program rollout.The study is observational, and there is no…

Read more